The chief scientific officer at Neurogen Biomarking outlined a novel home-based diagnostic model that can accelerate detection of early AD through biomarker profiling. [WATCH TIME: 5 minutes]
Elisabeth Thijssen, PhD
Advertisement
Chief scientific officer at Neurogen Biomarking.
Articles by Elisabeth Thijssen, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Designing the Phase 3 EMPEROR Trial and Future Considerations
2
NeurologyLive® Brain Games: November 2, 2025
3
AI in MS: IJMSC Survey Results
4
NeurologyLive® Friday 5 — October 31, 2025
5
